Introduction
Invasive aspergillosis has long been recognized as one of the most significant and often fatal opportunistic fungal infections in liver transplant recipients. [1] [2] [3] After Candida, Aspergillus species are responsible for most of the systemic fungal infections in the immunocompromised host. Noticeably, when the insult involves the Central Nervous System (CNS), Aspergillus is the second most common pathogen after Cryptococcus Neoformans. 4 Although the frequency of invasive aspergillosis ranges only from 1 to 6%, the mortality in these patients exceeds 90%, especially when the CNS is affected. 5 We report a case of a liver transplant recipient who developed an Aspergillus fumigatus brain abscess that produced significant neurologic symptoms. The patient was managed successfully with a combination of surgery and medical treatment with Voriconazole. To our knowledge, this is the second such case reported in the literature.
Case Report
A 59-year-old Caucasian female underwent orthotopic liver transplantation for HCV-related end-stage liver disease. She had a past medical history of HCV infection. There was no evidence of any infection in the donor. Immunosuppression Successful, combined long-term treatment of cerebral aspergillosis in a liver transplant patient Three months post-transplantation, she manifested partial seizures. Neurological examination revealed a slight right upper limb paresis and an intact level of consciousness and cognition. The seizures were acutely controlled with intravenous clonazepam (0.5-1 mg IV bolus injection). The patient was then given Levetiracetam orally (500 mg X2/day) on a systematic basis. Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) of the brain displayed a single solid mass (1.4 by 1.6 by 1.9 cm) in the left frontoparietal lobe, Figure 1 . The lesion was surrounded by extensive perifocal edema and demonstrated ring enhancement after contrast administration. Due to the altered immune status of the patient, the diagnosis of a brain abscess versus a metastatic mass was initially considered. The decision to proceed with surgery under neuronavigation was made. During the operation, the tumor was found about 1.5 cm from the cerebral cortex and excised easily en bloc, as a solid mass. Pathological examination revealed an abscess with the septate hyphae of Aspergillus fumigatus, Figure 2 .
The postoperative course of the patient was uneventful. She was slowly weaned off the antiseizure medication at the 6-month time point. Sinus and pulmonary CTs did not reveal any additional Aspergillus infection. She was also treated with Voriconazole at a dose of 200 mg twice a day orally for six months. Moreover, during the follow-up period she was tested monthly for serum Galactomannan antigen, in addition to surveillance for CMV once every two weeks.
At the 18 month follow-up she was seizure-free, with normal muscle power, while on an MRI there was no evidence of recurrence of the brain lesions. There was an effort to maintain her immunosuppression at an overall lower level (Cyclosporine level around 60-100 ng/mL), given her history of infections and HCV.
Invasive aspergillosis has long been recognized as one of the most significant and often fatal opportunistic fungal infections in liver transplant recipients. We report a case of a liver transplant recipient who developed an Aspergillus fumigatus brain abscess that produced significant neurologic symptoms. The patient was managed successfully with a combination of surgery and medical treatment with Voriconazole. To our knowledge, this is the second such case reported in the literature.
LeTTer TO THe eDITOr LeTTer TO THe eDITOr recipients were fatal, as antifungal medications alone did not prove to be effective in treating the infection 4, [11] [12] [13] [14] [15] [16] (Table 1 ). In the one of the two patients who survived, there were significant treatment-related side-effects, with the predominant one being renal failure due to antifungal medication nephrotoxicity. 4 Interestingly, of the reported cases, no patient was treated with Voriconazole. 4, [11] [12] [13] [14] [15] [16] In our patient, the combination of treatment with surgery and Voriconazole proved to be effective in achieving an uncomplicated, long-term, favorable outcome.
Treatment of cerebral aspergillosis in an immunocompromised patient has to be approached on several different levels. Specifically, the immunosuppression issue should be addressed, with the goal of reducing the level of overall immune suppression. This is complicated by the fact that in a liver transplant recipient, immunosuppression cannot be completely abandoned, due to the life-saving nature of the graft. Moreover, several antibiotics used for Aspergillus treatment, including Voriconazole, increase cyclosporine and tacrolimus concentrations, and therefore dosing adjustments to maintain appropriate levels are needed. 17 This brings us to the second issue, which is the choice of the antifungal antibiotic. Traditionally, Amphotericin B and subsequently liposomal amphotericin Our case did present within the expected timeframe, as symptoms started 3 months after liver transplantation and some of the risk factors were present. Specifically, she had a history of antimicrobial treatment (2 weeks) for the infected ascitic fluid, as well as a CMV infection for which she underwent prolonged (6 months) treatment. Furthermore, around the time of her hospitalization, there had been some minor construction work in the vicinity of the transplant unit. However, no other cases of Aspergillus were subsequently reported in our patients during that time period.
In the literature, most reported cases of cerebral aspergillosis in liver transplant
Discussion
Numerous factors have been associated with fungal infections in liver transplant recipients. These include prolonged operative time, increased intraoperative infusion of blood products, gastrointestinal or vascular complications, use of antibiotics and steroids, HCV infection, retransplantation, preexisting CMV infection and human herpes virus 6 (HHV6) seronegativity before transplantation. [6] [7] [8] [9] [10] Patients are placed in a state of higher immunosuppression, thus increasing their vulnerability to Aspergillus. The majority of these infections occur in the first 6 months after transplantation, when immunosuppression is at its highest level. approach combining surgical and medical treatment.
have been the predominant choices for Aspergillus treatment; however, serious side-effects such as nephrotoxicity and decreased cerebrospinal fluid (CSF) concentrations have limited its usefulness. 18 Voriconazole as therapy for invasive aspergillosis in immunocompromised patients has shown excellent results compared to Amphotericin B, as well as the advantage of oral bioavailability. [19] [20] [21] [22] [23] In the present case, a multi-pronged strategy was applied. The final key to the successful management was the immediate decision to proceed with neurosurgical intervention, which was critical from both a diagnostic and a therapeutic standpoint. With the aid of neuronavigation, a minimal surgical approach was carried out and the mass was removed en bloc, without damaging any areas of the brain. Neuronavigation provides intraoperative orientation of the surgeon and delineates the surrounding neurovascular structures. When needed, fusion of neuronavigation images with the functional data provided by MRI and EEG helps to avoid injuring vital areas of the brain during surgery. 24 In the present case the use of neuronavigation provided excellent accuracy, facilitated the precise planning of the craniotomy and guided the surgeons to the exact location of the tumor. Moreover, surgery was central in allowing a quick resolution of the problem, so that it was not necessary to wait for the antibiotic course to take effect. This way it was possible to decrease the risk of rejection by maintaining the reduced immunosuppression for no longer than absolutely necessary.
In conclusion, cerebral aspergillosis represents a very difficult problem for the liver transplant recipient, with a highly lethal course. Although, in high-risk patients, attempts for antifungal prophylaxis can be made, their efficacy regarding aspergillosis remains questionable. The key elements toward a successful outcome in such cases are a prompt diagnosis, through careful investigation of the presenting neurologic symptoms, identification of the offending microorganism, and, most importantly, an aggressive 
